CMC is constantly assessing medical devices and technologies that are needed by the Chinese surgeons and clinicians and more importantly, the Chinese patients.
We often find that while Western products and solutions might have a distinct and compelling value proposition for the China market, the companies have limited resources, time and finances, to consider China.
In these cases, CMC will consider committing its own capital, resources and capabilities to enter the China market in a combined venture with the device company ensuring that all interests are properly aligned. We feel that this approach not only benefits our client, but also the Chinese healthcare community.
When needed, CMC can commit its own capital and resources to benefit our client, and subsequently, the Chinese healthcare community.